These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 35016491)
1. Assessing the COVID-19 vaccine hesitancy in the Chinese adults using a generalized vaccine hesitancy survey instrument. Shen X; Dong H; Feng J; Jiang H; Dowling R; Lu Z; Lv C; Gan Y Hum Vaccin Immunother; 2021 Nov; 17(11):4005-4012. PubMed ID: 35016491 [TBL] [Abstract][Full Text] [Related]
2. Determinants of COVID-19 vaccine hesitancy: questionnaire development and validation. Cvjetković S; Jeremić Stojković V; Piperac P; Djurdjević O; Bjegović-Mikanović V Cent Eur J Public Health; 2022 Jun; 30(2):99-106. PubMed ID: 35876598 [TBL] [Abstract][Full Text] [Related]
3. Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument. Luyten J; Bruyneel L; van Hoek AJ Vaccine; 2019 Apr; 37(18):2494-2501. PubMed ID: 30940484 [TBL] [Abstract][Full Text] [Related]
4. Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV. Rodriguez VJ; Alcaide ML; Salazar AS; Montgomerie EK; Maddalon MJ; Jones DL AIDS Behav; 2022 Jan; 26(1):96-101. PubMed ID: 34138378 [TBL] [Abstract][Full Text] [Related]
6. Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale. Kotta I; Kalcza-Janosi K; Szabo K; Marschalko EE Hum Vaccin Immunother; 2022 Dec; 18(1):1-10. PubMed ID: 34919494 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study. Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y Front Immunol; 2021; 12():781161. PubMed ID: 34912346 [TBL] [Abstract][Full Text] [Related]
8. Psychometric validation of a chinese version of COVID-19 vaccine hesitancy scale: a cross-sectional study. Huang Y; Wu Y; Dai Z; Xiao W; Wang H; Si M; Wang W; Gu X; Ma L; Li L; Zhang S; Yang C; Yu Y; Qiao Y; Su X BMC Infect Dis; 2022 Oct; 22(1):765. PubMed ID: 36183087 [TBL] [Abstract][Full Text] [Related]
9. Changes in COVID-19 vaccine hesitancy at different times among residents in Guangzhou, China. Chen L; Li Z; Lu X; Deng Y; Lu K; Li T; Lu L; Wang Z; Lu J Front Public Health; 2023; 11():1164475. PubMed ID: 37383261 [TBL] [Abstract][Full Text] [Related]
10. Sociodemographic and psychosocial factors associated with vaccine hesitancy - results from a longitudinal study in Singapore. Subramaniam M; Abdin E; Shafie S; Shahwan S; Zhang Y; Satghare P; Devi F; Lun P; Yuxuan Ni M; Chong SA Hum Vaccin Immunother; 2023 Aug; 19(2):2235964. PubMed ID: 37489273 [TBL] [Abstract][Full Text] [Related]
11. Barriers to COVID-19 vaccination among medical students in Kazakhstan: development, validation, and use of a new COVID-19 Vaccine Hesitancy Scale. Bolatov AK; Seisembekov TZ; Askarova AZ; Pavalkis D Hum Vaccin Immunother; 2021 Dec; 17(12):4982-4992. PubMed ID: 34614385 [TBL] [Abstract][Full Text] [Related]
12. Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China. Akel KB; Masters NB; Shih SF; Lu Y; Wagner AL Hum Vaccin Immunother; 2021 Aug; 17(8):2639-2646. PubMed ID: 33769209 [TBL] [Abstract][Full Text] [Related]
13. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial. Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843 [TBL] [Abstract][Full Text] [Related]
14. Investigation on the hesitancy of COVID-19 vaccination among liver transplant recipients: A cross-sectional study in China. Pan Y; Gong S; Zhu X; Xue C; Jing Y; Sun Y; Qian Y; Zhang J; Xia Q Front Public Health; 2022; 10():1014942. PubMed ID: 36589975 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey. Luk TT; Zhao S; Wu Y; Wong JY; Wang MP; Lam TH Vaccine; 2021 Jun; 39(27):3602-3607. PubMed ID: 34034950 [TBL] [Abstract][Full Text] [Related]
16. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey. Hong J; Xu XW; Yang J; Zheng J; Dai SM; Zhou J; Zhang QM; Ruan Y; Ling CQ J Integr Med; 2022 Jan; 20(1):34-44. PubMed ID: 34774463 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccine hesitancy among Chinese residents under the free vaccination policy. Liu H; Zhou Z; Tao X; Huang L; Zhu E; Yu L; Zhang M Rev Assoc Med Bras (1992); 2021 Sep; 67(9):1317-1321. PubMed ID: 34816927 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 Vaccine-Related Attitudes and Beliefs in Canada: National Cross-sectional Survey and Cluster Analysis. Benham JL; Atabati O; Oxoby RJ; Mourali M; Shaffer B; Sheikh H; Boucher JC; Constantinescu C; Parsons Leigh J; Ivers NM; Ratzan SC; Fullerton MM; Tang T; Manns BJ; Marshall DA; Hu J; Lang R JMIR Public Health Surveill; 2021 Dec; 7(12):e30424. PubMed ID: 34779784 [TBL] [Abstract][Full Text] [Related]
19. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK. Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey. Zheng W; Sun Y; Li H; Zhao H; Zhan Y; Gao Y; Hu Y; Li P; Lin YF; Chen H; Meng H; Yang C; Fang Q; Yuan J; Jiang Y; Liu S; Cai Y; Zou H Hum Vaccin Immunother; 2021 Dec; 17(12):4971-4981. PubMed ID: 34890297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]